By contrast, all other tested somatic mutations detected in tumor-infiltrating leukocytes, including in known leukemia genes (DNMT3A, TET2, and BCOR, Table 2) were not identified in breast cancer cells consistent with their origin in the leukocyte component (Supplementary Table 4). The gene discussed is TET2; the disease is breast carcinoma.